Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05472337
PHASE2

Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome

Sponsor: Pontificia Universidad Catolica de Chile

View on ClinicalTrials.gov

Summary

This randomized clinical trial will determine the treatment effect of colchicine (1.5 mg loading dose and 0.5 mg daily thereafter) for 6 weeks on microvascular coronary reperfusion and infarct size in patients with acute coronary syndrome.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2022-08-01

Completion Date

2026-06-30

Last Updated

2025-05-31

Healthy Volunteers

No

Interventions

DRUG

Colchicine

Oral colchicine (1 mg loading dose followed by 0.5 mg 1 hour later, administered 6 to 24 hours before angioplasty, followed by 0.5 mg (1 comp.) per day for 6 weeks.

Locations (1)

Hospital Clínico Pontificia Universidad Catolica de Chile

Santiago, Santiago Metropolitan, Chile